These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12357859)

  • 21. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.
    Rudolph RL; Fabre LF; Feighner JP; Rickels K; Entsuah R; Derivan AT
    J Clin Psychiatry; 1998 Mar; 59(3):116-22. PubMed ID: 9541154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.
    Benkert O; Gründer G; Wetzel H; Hackett D
    J Psychiatr Res; 1996; 30(6):441-51. PubMed ID: 9023787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venlafaxine: a new antidepressant drug.
    Holdcroft C
    Nurse Pract; 1994 Sep; 19(9):21. PubMed ID: 7816367
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid onset of antidepressant activity with venlafaxine.
    Weisler RH; van Meter S
    J Clin Psychiatry; 2002 Jun; 63(6):534-5; author reply 535-6. PubMed ID: 12088168
    [No Abstract]   [Full Text] [Related]  

  • 25. Alternative venlafaxine kinetics in overdose.
    Langford NJ; Martin U; Ruprah M; Ferner RE
    J Clin Pharm Ther; 2002 Dec; 27(6):465-7. PubMed ID: 12472987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects.
    Ciusani E; Zullino DF; Eap CB; Brawand-Amey M; Brocard M; Baumann P
    J Psychopharmacol; 2004 Dec; 18(4):559-66. PubMed ID: 15582923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study.
    Allgulander C; Hackett D; Salinas E
    Br J Psychiatry; 2001 Jul; 179():15-22. PubMed ID: 11435263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium augmentation of venlafaxine in adolescent major depression.
    Walter G; Lyndon B; Kubb R
    Aust N Z J Psychiatry; 1998 Jun; 32(3):457-9. PubMed ID: 9672738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
    Rudolph RL; Feiger AD
    J Affect Disord; 1999 Dec; 56(2-3):171-81. PubMed ID: 10701474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
    Guelfi JD; Ansseau M; Timmerman L; Kørsgaard S;
    J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Venlafaxine-containing prolonged release: critical exchange?].
    Saussele T
    Med Monatsschr Pharm; 2009 Jul; 32(7):239. PubMed ID: 19731750
    [No Abstract]   [Full Text] [Related]  

  • 33. The patient with comorbid depression and anxiety: the unmet need.
    Bakish D
    J Clin Psychiatry; 1999; 60 Suppl 6():20-4. PubMed ID: 10235121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group.
    Clerc GE; Ruimy P; Verdeau-Pallès J
    Int Clin Psychopharmacol; 1994 Sep; 9(3):139-43. PubMed ID: 7814822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anxiety disorders: diagnosis and therapy from the family physician's perspective].
    Boerner RJ
    MMW Fortschr Med; 2006 May; Spec no. 2():62, 64-6. PubMed ID: 20104717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Depressive disorders and antidepressive therapy. A comparison of neurology practice and psychiatric clinic].
    Linden M; Ludewig K; Munz T
    Nervenarzt; 2001 Jul; 72(7):521-8. PubMed ID: 11478223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
    Thase ME
    J Clin Psychiatry; 1997 Sep; 58(9):393-8. PubMed ID: 9378690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
    Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
    Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Not neglecting therapy of depression in the elderly].
    MMW Fortschr Med; 2006 Apr; 148(16):56-7. PubMed ID: 16688953
    [No Abstract]   [Full Text] [Related]  

  • 40. High-dose venlafaxine in delusional and severely depressed patients.
    Ruiz-Doblado S; Rueda-Villar T; Casillas-Lara L
    J Psychopharmacol; 2009 Sep; 23(7):859-60. PubMed ID: 18562440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.